VYNE
VYNE THERAPEUTICS INC
CUSIP: 92941V308
VYNE THERAPEUTICS INC (VYNE) — institutional ownership and SEC 13F holdings data. Source: SEC EDGAR 13F filings.
About
VYNE Therapeutics is a clinical-stage specialty pharmaceutical company focused on developing and commercializing therapies for dermatologic conditions. The company advances prescription treatments for inflammatory and cosmetic skin disorders, primarily in the U.S., and relies on clinical programs and strategic collaborations to build its pipeline and commercial capabilities.
Institutional Holders
Source: SEC EDGAR 13F-HR filings from institutional investment managers.
AI Agent
Try asking...